Delivery Order SPE2DB22D3016-SPE2DB26FAAW9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,205.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $11,831.93 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supplies to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $22,965.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $13,398.50 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical transaction under AmerisourceBergen's existing contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $20,558.69 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on September 19, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The award was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, reflecting AmerisourceBergen's role as a major...
- The Defense Logistics Agency awarded a $26.7K delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with an ultimate completion date of September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government, leveraging...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAW9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,845.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs and veteran services. The company's federal contract portfolio demonstrates significant capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitive contract awards with the Defense Logistics Agency and related defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 10/29/25 |